The Competition Commission of India (CCI) has cleared Mankind Pharma’s acquisition of Bharat Serums and Vaccines in a ₹13,630-crore deal. In a statement on Wednesday, the regulator said: “The proposed...
CCI clears Rs 13,630-cr Mankind Pharma-Bharat Serums Vaccines deal
The Competition Commission of India (CCI) on Tuesday approved the proposed acquisition of Bharat Serums and Vaccines by Mankind Pharma for Rs 13,630 crore. Listed firm Mankind Pharma is engaged in developing...
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.6%...
Dr Reddy’s Laboratories completes acquisition of Haleon’s NRT portfolio
Dr Reddy’s Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc’s global portfolio of consumer healthcare brands, outside of the US, in the Nicotine...
Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore merger
Sequent Scientific and Viyash Life Sciences have announced a merger that will result in the two companies forming a combination that will create a platform with leadership in animal pharmaceuticals, end-to-end...
Aurobindo to acquire 49 pc stake in GLS Pharma for Rs 22.5 cr
Aurobindo Pharma Ltd on Wednesday said it will acquire the balance 49 per cent stake in GLS Pharma Ltd for Rs 22.5 crore to make the latter a wholly-owned subsidiary. The company has entered into a binding agreement on...
Natco Pharma acquires 40 million shares in eGenesis Inc
Natco Pharma Ltd on Wednesday said its Canadian subsidiary acquired 40 million shares in eGenesis Inc., a biotechnology company at the forefront of xenotransplantation focused on developing safe and effective human...
Semnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln deal
Semnur Pharmaceuticals, a wholly owned subsidiary of Scilex Holding Company, will go public via a merger with special purpose acquisition company Denali Capital Acquisition Corp in a $2.5 billion deal, the companies...
Fairfax, Bain look to buy Gujarat API company Farmson
Canadian billionaire Prem Watsa’s Fairfax Group and Bain Capital are vying for a buyout of Vadodara-based active pharmaceuticals ingredient (API) maker Farmson Basic Drugs in a deal valuing the company at ₹4,000...
Zydus Lifesciences acquires 50% stake in Sterling Biotech
Zydus Lifesciences said it has entered into an agreement with Temasek-backed Perfect Day to acquire a 50 percent stake in Sterling Biotech. Post the transaction, Sterling Biotech will become a 50:50 joint venture (JV)...
Torrent, Zydus, EQT set to make the cut for $3 bn JB Chemicals buyout
Torrent Pharma and Zydus Lifesciences are set to battle it out for JB Chemicals and Pharmaceuticals, the fifth and the sixth largest Indian drugmakers, along with possibly EQT and others, said people with knowledge of...
Roche considering divesting $1.9 bln cancer data startup, FT reports
Swiss pharmaceutical company Roche is considering divesting cancer data specialist Flatiron Health, the Financial Times reported on Wednesday, citing people familiar with the matter. Roche had paid $1.9 billion for New...
